VERTEX PHARMACEUTICALS INC / MA Interest Paid, Including Capitalized Interest, Operating and Investing Activities
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $33.44 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-07-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2018-07-26
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for the quarter ending 2018-06-30 was $16.62M, a 4.90% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for the quarter ending 2018-03-31 was $16.82M, a 4.01% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-12-31 was $16.71M, a 12.05% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for the quarter ending 2017-09-30 was $16.99M, a 27.21% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for fiscal 2017 was $68.70M, a 17.88% decline from fiscal 2016.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $83.66M, a 2.29% decline from fiscal 2015.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $85.61M, a 24.14% increase from fiscal 2014.
- VERTEX PHARMACEUTICALS INC / MA interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $68.96M, a 412.43% increase from fiscal 2013.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month as first filed | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month as first filed | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month as first filed | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $16.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $33.44M 10-Q · filed 2018-07-26 | $50.15M derived: sum of 3 quarters · filed 2018-07-26 | $67.14M derived: sum of 4 quarters · filed 2018-07-26 | ||||
| 2018-03-31 | $16.82M 10-Q · filed 2018-04-27 | $33.53M derived: sum of 2 quarters · filed 2018-04-27 | $50.52M derived: sum of 3 quarters · filed 2018-04-27 | $67.99M derived: sum of 4 quarters · filed 2018-07-26 | ||||
| 2017-12-31 | $16.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $33.69M derived: sum of 2 quarters · filed 2018-02-15 | $51.17M derived: sum of 3 quarters · filed 2018-07-26 | $68.70M 10-K · filed 2018-02-15 | ||||
| 2017-09-30 | $16.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $34.46M derived: sum of 2 quarters · filed 2018-07-26 | $51.99M 10-Q · filed 2017-10-30 | $70.98M derived: sum of 4 quarters · filed 2018-07-26 | ||||
| 2017-06-30 | $17.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $35.00M 10-Q · filed 2018-07-26 | $54.00M derived: sum of 3 quarters · filed 2018-07-26 | $77.33M derived: sum of 4 quarters · filed 2018-07-26 | ||||
| 2017-03-31 | $17.53M 10-Q · filed 2018-04-27 | $36.52M derived: sum of 2 quarters · filed 2018-04-27 | $59.86M derived: sum of 3 quarters · filed 2018-04-27 | $80.58M derived: sum of 4 quarters · filed 2018-04-27 | ||||
| 2016-12-31 | $18.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $42.33M derived: sum of 2 quarters · filed 2018-02-15 | $63.05M derived: sum of 3 quarters · filed 2018-02-15 | $83.66M 10-K · filed 2018-02-15 | ||||
| 2016-09-30 | $23.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $44.06M derived: sum of 2 quarters · filed 2017-10-30 | $64.66M 10-Q · filed 2017-10-30 | $86.04M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $20.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $41.33M 10-Q · filed 2017-07-28 | $62.71M derived: sum of 3 quarters · filed 2018-02-15 | $84.05M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $20.60M 10-Q · filed 2017-04-28 | $41.98M derived: sum of 2 quarters · filed 2018-02-15 | $63.33M derived: sum of 3 quarters · filed 2018-02-15 | $84.68M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $21.38M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $42.73M derived: sum of 2 quarters · filed 2018-02-15 | $64.08M derived: sum of 3 quarters · filed 2018-02-15 | $85.61M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $21.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $42.69M derived: sum of 2 quarters · filed 2016-10-31 | $64.23M 10-Q · filed 2016-10-31 | $19.07M 10-Q · filed 2015-10-30 | $130.38M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | $21.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $42.88M 10-Q · filed 2016-08-01 | $12.78M 10-Q · filed 2015-08-04 | $109.03M derived: sum of 3 quarters · filed 2017-02-23 | $79.92M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $21.54M 10-Q · filed 2016-05-03 | $6.48M 10-Q · filed 2015-05-04 | $87.68M derived: sum of 2 quarters · filed 2017-02-23 | $58.57M derived: sum of 3 quarters · filed 2017-02-23 | $74.53M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $66.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $37.03M derived: sum of 2 quarters · filed 2017-02-23 | $52.99M derived: sum of 3 quarters · filed 2017-02-23 | $68.96M 10-K · filed 2017-02-23 | $8.71M 10-K · filed 2015-02-13 | |||
| 2014-09-30 | -$29.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$13.15M derived: sum of 2 quarters · filed 2015-10-30 | $2.82M 10-Q · filed 2015-10-30 | $8.64M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $15.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $31.93M 10-Q · filed 2015-08-04 | $37.75M derived: sum of 3 quarters · filed 2016-02-16 | $38.25M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | $15.97M 10-Q · filed 2015-05-04 | $21.79M derived: sum of 2 quarters · filed 2016-02-16 | $22.29M derived: sum of 3 quarters · filed 2016-02-16 | $29.18M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $6.32M derived: sum of 2 quarters · filed 2016-02-16 | $13.21M derived: sum of 3 quarters · filed 2016-02-16 | $13.46M 10-K · filed 2016-02-16 | $11.02M 10-K · filed 2014-02-11 | |||
| 2013-09-30 | $495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $7.39M derived: sum of 2 quarters · filed 2014-11-06 | $7.64M 10-Q · filed 2014-11-06 | $6.70M 10-Q · filed 2013-11-07 | $14.34M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $7.14M 10-Q · filed 2014-07-31 | $6.70M 10-Q · filed 2013-08-02 | $13.84M derived: sum of 3 quarters · filed 2015-02-13 | $13.84M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $243.00K 10-Q · filed 2014-05-05 | $6.94M derived: sum of 2 quarters · filed 2015-02-13 | $6.94M derived: sum of 3 quarters · filed 2015-02-13 | $13.64M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $6.70M derived: sum of 2 quarters · filed 2015-02-13 | $13.40M derived: sum of 3 quarters · filed 2015-02-13 | $13.40M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.70M derived: sum of 2 quarters · filed 2013-11-07 | $6.70M 10-Q · filed 2013-11-07 | $13.40M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $6.70M 10-Q · filed 2013-08-02 | $13.40M derived: sum of 3 quarters · filed 2014-02-11 | $13.40M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-10 | $6.70M derived: sum of 2 quarters · filed 2014-02-11 | $6.70M derived: sum of 3 quarters · filed 2014-02-11 | |||||
| 2011-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $6.70M derived: sum of 2 quarters · filed 2014-02-11 | $13.51M 10-K · filed 2014-02-11 | |||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $6.81M 10-Q · filed 2012-11-06 | ||||||
| 2011-06-30 | $6.81M 10-Q · filed 2012-08-08 | |||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $0.00 derived: sum of 2 quarters · filed 2013-03-01 | $0.00 derived: sum of 3 quarters · filed 2013-03-01 | $761.00K 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $0.00 derived: sum of 2 quarters · filed 2011-11-03 | $761.00K 10-Q · filed 2011-11-03 | $761.00K derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $761.00K 10-Q · filed 2011-08-09 | $761.00K derived: sum of 3 quarters · filed 2012-02-22 | $4.18M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $761.00K 10-Q · filed 2011-05-06 | $761.00K derived: sum of 2 quarters · filed 2012-02-22 | $4.18M derived: sum of 3 quarters · filed 2012-02-22 | $4.18M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $3.42M derived: sum of 2 quarters · filed 2012-02-22 | $3.42M derived: sum of 3 quarters · filed 2012-02-22 | $10.25M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $3.42M derived: sum of 2 quarters · filed 2010-10-28 | $10.25M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-03 | $6.83M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | $6.83M 10-Q · filed 2010-05-03 | |||||||
| 2008-12-31 | $6.68M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |